Stock Track | BAO PHARMA-B Soars 6.67% Intraday on Chairman's Share Purchase Plan and Proposed Buyback Authorization

Stock Track05-04

BAO PHARMA-B's stock price soared 6.67% during intraday trading on Monday, marking a significant rebound for the pharmaceutical company.

The surge follows an announcement that Board Chairman and controlling shareholder Dr. Liu Yanjun plans to increase his holdings of the company's shares through open market transactions within three months, expressing confidence in the group's prospects, growth potential, and long-term investment value. Additionally, the company intends to propose a special resolution at the upcoming Annual General Meeting to authorize directors to repurchase up to 10% of total issued H shares.

The board confirmed that the group's business operations remain normal with no material changes in its operational or financial condition. This positive movement comes after the stock experienced a sharp decline previously attributed to an expanded full-year net loss.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133074617?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 09:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133074617","market":"nz","top_or_hot":-1,"title":"Stock Track | BAO PHARMA-B Soars 6.67% Intraday on Chairman's Share Purchase Plan and Proposed Buyback Authorization","media":"Stock Track","content":"<p>BAO PHARMA-B's stock price soared 6.67% during intraday trading on Monday, marking a significant rebound for the pharmaceutical company.</p><p>The surge follows an announcement that Board Chairman and controlling shareholder Dr. Liu Yanjun plans to increase his holdings of the company's shares through open market transactions within three months, expressing confidence in the group's prospects, growth potential, and long-term investment value. Additionally, the company intends to propose a special resolution at the upcoming Annual General Meeting to authorize directors to repurchase up to 10% of total issued H shares.</p><p>The board confirmed that the group's business operations remain normal with no material changes in its operational or financial condition. This positive movement comes after the stock experienced a sharp decline previously attributed to an expanded full-year net loss.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BAO PHARMA-B Soars 6.67% Intraday on Chairman's Share Purchase Plan and Proposed Buyback Authorization</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BAO PHARMA-B Soars 6.67% Intraday on Chairman's Share Purchase Plan and Proposed Buyback Authorization\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 09:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAO PHARMA-B's stock price soared 6.67% during intraday trading on Monday, marking a significant rebound for the pharmaceutical company.</p><p>The surge follows an announcement that Board Chairman and controlling shareholder Dr. Liu Yanjun plans to increase his holdings of the company's shares through open market transactions within three months, expressing confidence in the group's prospects, growth potential, and long-term investment value. Additionally, the company intends to propose a special resolution at the upcoming Annual General Meeting to authorize directors to repurchase up to 10% of total issued H shares.</p><p>The board confirmed that the group's business operations remain normal with no material changes in its operational or financial condition. This positive movement comes after the stock experienced a sharp decline previously attributed to an expanded full-year net loss.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1133074617","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133074617","pubTimestamp":1777859346,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BAO PHARMA-B's stock price soared 6.67% during intraday trading on Monday, marking a significant rebound for the pharmaceutical company.The surge follows an announcement that Board Chairman and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"股票轨迹|宝药业-B盘中大涨6.67%因主席购股计划及建议回购授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"BAO PHARMA-B's stock price soared 6.67% during intraday trading on Monday, marking a significant rebound for the pharmaceutical company.The surge follows an announcement that Board Chairman and controlling shareholder Dr. Liu Yanjun plans to increase his holdings of the company's shares through open market transactions within three months, expressing confidence in the group's prospects, growth potential, and long-term investment value. Additionally, the company intends to propose a special resolution at the upcoming Annual General Meeting to authorize directors to repurchase up to 10% of total issued H shares.The board confirmed that the group's business operations remain normal with no material changes in its operational or financial condition. This positive movement comes after the stock experienced a sharp decline previously attributed to an expanded full-year net loss.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133074617","isCrawlerRequest":true}